Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Authors:

Abstract
Neurodegeneration in Parkinson’s disease (PD) precedes diagnosis by years. Early neurodegeneration may be reflected in RNA levels and measurable as a biomarker. Here, we present the largest quantification of whole blood linear and circular RNAs (circRNA) in early-stage idiopathic PD, using RNA sequencing data from two cohorts (PPMI = 259 PD, 161 Controls; ICICLE-PD = 48 PD, 48 Controls). We identified a replicable increase inTMEM252andLMNB1gene expression in PD. We identified novel differences in the expression of circRNAs fromESYT2,BMS1P1andCCDC9, and replicated trends of previously reported circRNAs. Overall, using circRNA as a diagnostic biomarker in PD did not show any clear improvement over linear RNA, minimising its potential clinical utility. More interestingly, we observed a general reduction in circRNA expression in both PD cohorts, accompanied by an increase inRNASELexpression. This imbalance implicates the activation of an innate antiviral immune response and suggests a previously unknown aspect of circRNA regulation in PD.
Funding Information
  • Michael J. Fox Foundation for Parkinson's Research (MJFF-007574, MJFF-007574, MJFF-007574)
  • Wellcome Trust (203105/Z/16/Z)
  • Parkinson's UK (J-0802, G-1301, G-1507, J-0802, G-1301, G-1507)
  • Parkinson's UK
  • Parkinson's UK
  • Parkinson's UK
  • Parkinson's UK
  • Parkinson's UK
  • Michael J. Fox Foundation for Parkinson's Research
  • Michael J. Fox Foundation for Parkinson's Research

This publication has 156 references indexed in Scilit: